Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6442)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2014 (publication date) through Dec 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang YJ, Li AJ, Han Y, Yin L, Lin MB. Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin. World J Gastroenterol 2014; 20(25): 8229-8236 [PMID: 25009397 DOI: 10.3748/wjg.v20.i25.8229] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i25/8229.htm |
| Number | Citing Articles |
| 1 |
Pradipta Ghosh, Nicolas Aznar, Lee Swanson, I‐Chung Lo, Inmaculada Lopez‐Sanchez, Jason Ear, Cristina Rohena, Nicholas Kalogriopoulos, Linda Joosen, Ying Dunkel, Nina Sun, Peter Nguyen, Deepali Bhandari. Biochemical, Biophysical and Cellular Techniques to Study the Guanine Nucleotide Exchange Factor, GIV/Girdin. Current Protocols in Chemical Biology 2016; 8(4): 265 doi: 10.1002/cpch.13
|
| 2 |
Moubin Lin, Yajie Zhang, Ajian Li, Erjiang Tang, Jian Peng, Wenxian Tang, Yong Zhang, Liang Lu, Yihua Xiao, Qing Wei, Lu Yin, Huaguang Li. High-throughput RNAi screening of human kinases identifies predictors of clinical outcome in colorectal cancer patients treated with oxaliplatin. Oncotarget 2015; 6(18): 16774 doi: 10.18632/oncotarget.3736
|
| 3 |
Nitin Bharat Charbe, Nikhil D. Amnerkar, B. Ramesh, Murtaza M. Tambuwala, Hamid A. Bakshi, Alaa A.A. Aljabali, Saurabh C. Khadse, Rajendran Satheeshkumar, Saurabh Satija, Meenu Metha, Dinesh Kumar Chellappan, Garima Shrivastava, Gaurav Gupta, Poonam Negi, Kamal Dua, Flavia C. Zacconi. Small interfering RNA for cancer treatment: overcoming hurdles in delivery. Acta Pharmaceutica Sinica B 2020; 10(11): 2075 doi: 10.1016/j.apsb.2020.10.005
|
| 4 |
Yixin Yin, Siqi Li, Xinqiang Liang, Kezhi Li, Mingzhi Xie, Bangli Hu. Construction and Validation of an Oxaliplatin-Resistant Gene Signature in Colorectal Cancer Patients Who Underwent Chemotherapy. Pharmaceuticals 2022; 15(9): 1139 doi: 10.3390/ph15091139
|
| 5 |
Man Zhu, Hao Li, Yi Zheng, Jing Yang. Targeting TOP2B as a vulnerability in aging and aging-related diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(3): 167044 doi: 10.1016/j.bbadis.2024.167044
|
| 6 |
Wei Sun, Yang Ge, Junpeng Cui, Yifan Yu, Baolin Liu. Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2. Molecular Therapy - Oncolytics 2021; 21: 87 doi: 10.1016/j.omto.2021.03.010
|
| 7 |
Chen Chen, Atsushi Enomoto, Liang Weng, Tetsuro Taki, Yukihiro Shiraki, Shinji Mii, Ryosuke Ichihara, Mitsuro Kanda, Masahiko Koike, Yasuhiro Kodera, Masahide Takahashi. Complex roles of the actin‐binding protein Girdin/GIV in DNA damage‐induced apoptosis of cancer cells. Cancer Science 2020; 111(11): 4303 doi: 10.1111/cas.14637
|
| 8 |
Nicolas Aznar, Nicholas Kalogriopoulos, Krishna K. Midde, Pradipta Ghosh. Heterotrimeric G protein signaling via GIV/Girdin: Breaking the rules of engagement, space, and time. BioEssays 2016; 38(4): 379 doi: 10.1002/bies.201500133
|
| 9 |
Ke Cao, Jingjing Li, Yong Zhao, Qi Wang, Qinghai Zeng, Siqi He, Li Yu, Jianda Zhou, Peiguo Cao. miR-101 Inhibiting Cell Proliferation, Migration and Invasion in Hepatocellular Carcinoma through Downregulating Girdin. Molecules and Cells 2016; 39(2): 96 doi: 10.14348/molcells.2016.2161
|
| 10 |
Jingmin Zhou, Guanghua Liu, Xingcheng Wu, Zhien Zhou, Jialin Li, Zhigang Ji, Hubertus Himmerich. A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/8863799
|
| 11 |
Michael Getz, Padmini Rangamani, Pradipta Ghosh. Regulating cellular cyclic adenosine monophosphate: “Sources,” “sinks,” and now, “tunable valves”. WIREs Systems Biology and Medicine 2020; 12(5) doi: 10.1002/wsbm.1490
|
| 12 |
Sheng Wang, Wei Feng, Wulin Wang, Xiaoman Ye, Hao Chen, Chunzhao Yu. Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.618764
|
| 13 |
Yun Wang, Qiang Fu, Yun-jian Tao, Sheng-nan Ying, Heng-gao Zhong, Yue Zhu, Xiao-han Qian, Lin Miao, Li-hua Yang. Girdin acts as an oncogene in gastric cancer by regulating AKT/GSK3β/β-catenin signaling. Functional & Integrative Genomics 2023; 23(1) doi: 10.1007/s10142-022-00927-8
|
| 14 |
Pradipta Ghosh, Jeanne Tie, Andrea Muranyi, Shalini Singh, Patrick Brunhoeber, Katherine Leith, Rebecca Bowermaster, Zhiming Liao, Yifei Zhu, Bonnie LaFleur, Ben Tran, Jayesh Desai, Ian Jones, Matthew Croxford, Rodrigo Jover, Ajay Goel, Paul Waring, Song Hu, Volker Teichgraber, Ulrich-Peter Rohr, Ruediger Ridder, Kandavel Shanmugam, Peter Gibbs. Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair–Proficient Stage II Colon Cancer. Clinical Cancer Research 2016; 22(14): 3488 doi: 10.1158/1078-0432.CCR-15-2290
|
| 15 |
Pradipta Ghosh. G protein coupled growth factor receptor tyrosine kinase:no longer an oxymoron. Cell Cycle 2015; 14(16): 2561 doi: 10.1080/15384101.2015.1066538
|
| 16 |
Molecular differences in the microsatellite stable phenotype between left‐sided and right‐sided colorectal cancer. International Journal of Cancer 2016; 139(11): 2493 doi: 10.1002/ijc.30377
|
| 17 |
Qiongying Hu, Yuchen Li, Hongqing Chen, Hongyan Liao, Yong He, Qin Zheng. RETRACTED: CCDC88A Post-Transcriptionally Regulates VEGF via miR-101 and Subsequently Regulates Hepatocellular Carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.859331
|
| 18 |
Naoko Iida, Yukari Muranaka, Jun Won Park, Shigeki Sekine, Neal G. Copeland, Nancy A. Jenkins, Yuichi Shiraishi, Masanobu Oshima, Haruna Takeda. Sleeping Beauty transposon mutagenesis in mouse intestinal organoids identifies genes involved in tumor progression and metastasis. Cancer Gene Therapy 2024; 31(4): 527 doi: 10.1038/s41417-023-00723-x
|
| 19 |
Seung-On Lee, Mee-Hyun Lee, Ah-Won Kwak, Jin-Young Lee, Goo Yoon, Sang Hoon Joo, Yung Hyun Choi, Jin Woo Park, Jung-Hyun Shim. Licochalcone H Targets EGFR and AKT to Suppress the Growth of Oxaliplatin -Sensitive and -Resistant Colorectal Cancer Cells. Biomolecules & Therapeutics 2023; 31(6): 661 doi: 10.4062/biomolther.2023.155
|
| 20 |
Pradipta Ghosh. The untapped potential of tyrosine-based G protein signaling. Pharmacological Research 2016; 105: 99 doi: 10.1016/j.phrs.2016.01.017
|
| 21 |
Lui Ng, Timothy Ming-Hun Wan, Deepak Narayanan Iyer, Zheng Huang, Ryan Wai-Yan Sin, Abraham Tak-Ka Man, Xue Li, Dominic Chi-Chung Foo, Oswens Siu-Hung Lo, Wai-Lun Law. High Levels of Tumor miR-187-3p—A Potential Tumor-Suppressor microRNA—Are Correlated with Poor Prognosis in Colorectal Cancer. Cells 2022; 11(15): 2421 doi: 10.3390/cells11152421
|
| 22 |
Pradipta Ghosh. Heterotrimeric G proteins as emerging targets for network based therapy in cancer: End of a long futile campaign striking heads of a Hydra. Aging 2015; 7(7): 469 doi: 10.18632/aging.100781
|
| 23 |
Zhong-Ying Ma, Xiao-Jing Ding, Zhen-Zhen Zhu, Qian Chen, Dong-Bo Wang, Xin Qiao, Jing-Yuan Xu. Pt(iv) derivatives of cisplatin and oxaliplatin bearing an EMT-related TMEM16A/COX-2-selective dual inhibitor against colorectal cancer cells HCT116. RSC Medicinal Chemistry 2024; 15(9): 3239 doi: 10.1039/D4MD00327F
|